122 filings
Page 5 of 7
CORRESP
oeac67vjtkgpsz0
18 May 21
Correspondence with SEC
12:00am
8-K
5l17opthgle8f53mxbv
17 May 21
Vivos Therapeutics Reports First Quarter 2021 Financial Results and Operational Update
4:15pm
10-Q
xvzq9lv3v7dgixlg
17 May 21
Quarterly report
4:10pm
8-K
g3p8tmg s6nid59p
12 May 21
Vivos Therapeutics Announces Closing of Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
5:21pm
424B4
q7w2xj8 3oswcsx7
10 May 21
Prospectus supplement with pricing info
5:06pm
EFFECT
bzk90putf10jg8
7 May 21
Notice of effectiveness
12:15am
S-1MEF
k3ml e4m53w
6 May 21
Registration of additional securities for an S-1
7:26pm
UPLOAD
i2lw6mupvv9p
4 May 21
Letter from SEC
12:00am
CORRESP
ky8nn3ozo35lxz6
4 May 21
Correspondence with SEC
12:00am
CORRESP
m42c0fgxm7o
4 May 21
Correspondence with SEC
12:00am
UPLOAD
ustr78r0u0bl71ul7x
20 Apr 21
Letter from SEC
12:00am
DRS
x0o2oa 4aq4h81
13 Apr 21
Draft registration statement
12:00am
8-K
h5q bomqt
2 Apr 21
Vivos Therapeutics to Launch MyoCorrect Orofacial Myofunctional Therapy Service
2:00pm
8-K
f2ghzvw3c9
25 Mar 21
Vivos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update
4:15pm
10-K
nvre y4lsj
25 Mar 21
Annual report
4:15pm
8-K
kc9jmenplw9b
19 Feb 21
Vivos Therapeutics Launches VivoScore Diagnostic Technology for Home Sleep Apnea Testing in Children and Adults
4:15pm
8-K
rn4oomlall o9785oy
15 Dec 20
Vivos Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
5:05pm